Deutsche Bank
PMVP icon

Deutsche Bank’s PMV Pharmaceuticals PMVP Stock Holding History

Deutsche Bank’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,616
Closed -$2.75K – 3669
2024
Q1 		$2.75K Hold
1,616
– – ﹤0.01% 3573
2023
Q4 		$5.01K Sell
1,616
-17,216
-91% -$45.6K ﹤0.01% 3567
2023
Q3 		$116K Buy
18,832
+293
+2% +$2.02K ﹤0.01% 3095
2023
Q2 		$116K Sell
18,539
-14,315
-44% -$75K ﹤0.01% 3208
2023
Q1 		$157K Buy
32,854
+12,806
+64% +$90.1K ﹤0.01% 3119
2022
Q4 		$174K Buy
20,048
+5,102
+34% +$54.4K ﹤0.01% 3051
2022
Q3 		$178K Sell
14,946
-2,467
-14% -$35.6K ﹤0.01% 3008
2022
Q2 		$248K Buy
17,413
+1,898
+12% +$27.6K ﹤0.01% 3048
2022
Q1 		$323K Sell
15,515
-44,695
-74% -$788K ﹤0.01% 3006
2021
Q4 		$1.39M Buy
60,210
+964
+2% +$23.3K ﹤0.01% 2232
2021
Q3 		$1.77M Sell
59,246
-484
-0.8% -$15.5K ﹤0.01% 2190
2021
Q2 		$2.04M Buy
59,730
+7,398
+14% +$247K ﹤0.01% 2201
2021
Q1 		$1.72M Buy
52,332
+12,036
+30% +$474K ﹤0.01% 2287
2020
Q4 		$2.48M Buy
+40,296
New +$1.58M ﹤0.01% 1801

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Deutsche Bank's PMVP Position: Q2 2024 in Review

Deutsche Bank sold out of PMV Pharmaceuticals (PMVP) in Q2 2024, closing a stake of 1,616 shares — an estimated $2.75K sold.

Deutsche Bank first reported a position in PMVP in Q4 2020 and held it in 14 quarters. The position peaked at $2.48M in Q4 2020. 93 funds tracked by Wall St. Rank hold PMVP as of Q2 2024.

  • Deutsche Bank reported no remaining PMV Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Deutsche Bank sold 1,616 PMV Pharmaceuticals shares in Q2 2024, an estimated $2.75K.
  • Deutsche Bank first reported a position in PMV Pharmaceuticals in Q4 2020 and held it in 14 quarters.
  • Deutsche Bank's PMV Pharmaceuticals position peaked at $2.48M in Q4 2020.
  • 93 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2024.

Based on Deutsche Bank's 13F filing for Q2 2024, filed 14 Aug 2024.